Variation in therapeutic strategies for the management of severe COVID‐19 in India: A nationwide cross‐sectional survey
Bharat Jagiasi, Prashant Nasa, Gunjan Chanchalani, Ahsan Ahmed, Ajith Kumar Ak, Kanwalpreet Sodhi, Kishore Mangal, Manoj K Singh, Nitesh Gupta, Prasanna U Bidkar, Ranvir S Tyagi, Reshu G Khanikar, Swagata Tripathy, Swapna Khanzode, Kesavarapu Subba Reddy, Saurabh Saigal, Vijay Anand Sivakumar, Yash Javeri, Seema S Tekwani
International Journal of Clinical Practice, doi:10.1111/ijcp.14574
Aim: During the pandemic of coronavirus disease 2019 (COVID-19), the physicians are using various off-label therapeutics to manage COVID-19. We undertook a crosssectional survey to study the current variation in therapeutic strategies for managing severe COVID-19 in India. Methods: From January 4 to January 18, 2021, an online cross-sectional survey was conducted among physicians involved in the management of severe COVID-19. The survey had three sections: 1. Antiviral agents, 2. Immunomodulators, and 3. Adjuvant therapies. Results: 1055 respondents (from 24 states and five union territories), of which 64.2% were consultants, 54.3% working in private hospitals, and 39.1% were from critical care medicine completed the survey. Remdesivir (95.2%), antithrombotics (94.2%),
prescribed antibiotics with severity of COVID-19 (58.3%) or increased inflammatory markers (56.4%) were preferred indications. There was significant variation in the use of adjuvant therapies with specialists from critical care medicine preferred use of antibiotics in severe and critical COVID-19, while anaesthesiologists preferred vitamins in all patients of COVID-19. Bacterial co-infections are uncommon in COVID-19 and vary from 3.5% at the time of admission to 15% among hospitalised patients. 28 A recent guideline on antimicrobials in COVID-19, recommended a restrictive approach and empirical antibiotics to be considered only if clinical, imaging and biochemical markers suggest a bacterial co-infection. The de-escalation of antibiotics within 48 hours is suggested if representative cultures or antigen tests excluded bacterial co-infection. 29 The authors did not recommend any empirical antibiotic regimen and advised to use community or hospital-acquired pneumonia guidelines while starting antibiotics and using local antimicrobial surveillance. 29 Recently, the RECOVERY trial found no role of azithromycin in the treatment of hospitalised COVID-19 patients. 30 The prepublication release from the PRINCIPAL trial using azithromycin or doxycycline for 14 days showed no significant benefit in time to recovery or hospitalisation. 31 NIH does not recommend vitamin C in COVID-19 because of insufficient data. 32 There are ongoing trials on intravenous vitamin C in..
References
Agarwal, Mukherjee, Kumar, Convalescent plasma in the management of moderate covid-19 in adults in India:open label phase II multicentre randomised controlled trial (PLACID Trial), BMJ
Alhazzani, Evans, Alshamsi, Surviving sepsis campaign guidelines on the management of adults with coronavirus disease 2019 (COVID-19) in the ICU: first update, Crit Care Med
Armstrong, Kane, Cook, Outcomes from intensive care in patients with COVID-19: a systematic review and meta-analysis of observational studies, Anaesthesia
Asch, Sheils, Islam, Variation in US hospital mortality rates for patients admitted with COVID-19 during the first 6 months of the pandemic, JAMA Intern Med
Beigel, Tomashek, Dodd, Remdesivir for the treatment of covid-19 -final report, N Engl J Med
Berlin, Gulick, Martinez, Severe covid-19, N Engl J Med
Borczuk, Salvatore, Seshan, COVID-19 pulmonary pathology: a multi-institutional autopsy cohort from Italy and New York City, Mod Pathol
Charan, Kaur, Bhardwaj, Snapshot of COVID-19 related clinical trials in India, Indian J Clin Biochem
Chatterjee, Is India missing COVID-19 deaths?, Lancet
Chow, Khanna, Kethireddy, Aspirin use is associated with decreased mechanical ventilation, ICU admission, and inhospital mortality in hospitalized patients with COVID-19, Anesth Analg
Dong, Du, Gardner, An interactive web-based dashboard to track COVID-19 in real time, Lancet Infect Dis
Gopalan, Misra, COVID-19 pandemic and challenges for socio-economic issues, healthcare and National Health Programs in India, Diabetes Metab Syndr
Grasselli, Greco, Zanella, Risk factors associated with mortality among patients with COVID-19 in intensive care units in Lombardy, Italy, JAMA Intern Med
He, Yi, Zhu, Estimation of the basic reproduction number, average incubation time, asymptomatic infection rate, and case fatality rate for COVID-19: meta-analysis and sensitivity analysis, J Med Virol
Horby, Lim, Emberson, Dexamethasone in hospitalized patients with covid-19 -preliminary report, N Engl J Med
Janiaud, Axfors, Schmitt, Association of convalescent plasma treatment with clinical outcomes in patients with COVID-19: a systematic review and meta-analysis, JAMA
Joshi, Parkar, Ansari, Role of favipiravir in the treatment of COVID-19, Int J Infect Dis
Lim, Subramaniam, Reddy, Case fatality rates for patients with COVID-19 requiring invasive mechanical ventilation. a meta-analysis, Am J Respir Crit Care Med
Murdaca, Pioggia, Negrini, Vitamin D and Covid-19: an update on evidence and potential therapeutic implications, Clin Mol Allergy
News, PRINCIPLE trial finds antibiotics azithromycin and doxycycline not generally effective treatments for COVID-19
Nice, COVID-19 rapid evidence summary: Tocilizumab for COVID-19
Nih, The COVID-19 Treatment Guidelines Panel's Statement on the Use of Ivermectin for the Treatment of COVID-19
Onder, Rezza, Brusaferro, Case-fatality rate and characteristics of patients dying in relation to COVID-19 in Italy, JAMA
Pan, Peto, Henao-Restrepo, Repurposed antiviral drugs for covid-19 -Interim WHO Solidarity trial results, N Engl J Med
Parr, Time to Reassess Tocilizumab's Role in COVID-19 Pneumonia, JAMA Intern Med
Sieswerda, De Boer, Bonten, Recommendations for antibacterial therapy in adults with COVID-19 -an evidence based guideline, Clin Microbiol Infect
Sterne, Murthy, Association between administration of systemic corticosteroids and mortality among critically Ill patients with COVID-19: a meta-analysis, JAMA
Wise, Covid-19: Arthritis drugs improve survival in intensive care patients, shows study, BMJ
Wu, Mcgoogan, Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese center for disease control and prevention, JAMA
Zhou, Yu, Du, Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study, Lancet
{ 'indexed': {'date-parts': [[2023, 8, 23]], 'date-time': '2023-08-23T17:34:36Z', 'timestamp': 1692812076672},
'reference-count': 35,
'publisher': 'Hindawi Limited',
'issue': '10',
'license': [ { 'start': { 'date-parts': [[2021, 7, 18]],
'date-time': '2021-07-18T00:00:00Z',
'timestamp': 1626566400000},
'content-version': 'vor',
'delay-in-days': 0,
'URL': 'http://onlinelibrary.wiley.com/termsAndConditions#vor'},
{ 'start': { 'date-parts': [[2021, 7, 18]],
'date-time': '2021-07-18T00:00:00Z',
'timestamp': 1626566400000},
'content-version': 'tdm',
'delay-in-days': 0,
'URL': 'http://doi.wiley.com/10.1002/tdm_license_1.1'}],
'content-domain': {'domain': ['onlinelibrary.wiley.com'], 'crossmark-restriction': True},
'published-print': {'date-parts': [[2021, 10]]},
'DOI': '10.1111/ijcp.14574',
'type': 'journal-article',
'created': {'date-parts': [[2021, 6, 25]], 'date-time': '2021-06-25T19:35:17Z', 'timestamp': 1624649717000},
'update-policy': 'http://dx.doi.org/10.1002/crossmark_policy',
'source': 'Crossref',
'is-referenced-by-count': 2,
'title': 'Variation in therapeutic strategies for the management of severe COVID‐19 in India: A nationwide '
'cross‐sectional survey',
'prefix': '10.1155',
'volume': '75',
'author': [ { 'given': 'Bharat',
'family': 'Jagiasi',
'sequence': 'first',
'affiliation': [ { 'name': 'Critical Care Department Reliance Hospital Navi Mumbai '
'Maharashtra India'}]},
{ 'ORCID': 'http://orcid.org/0000-0003-1948-4060',
'authenticated-orcid': False,
'given': 'Prashant',
'family': 'Nasa',
'sequence': 'additional',
'affiliation': [ { 'name': 'Critical Care Medicine NMC Specialty Hospital Dubai United Arab '
'Emirates'}]},
{ 'given': 'Gunjan',
'family': 'Chanchalani',
'sequence': 'additional',
'affiliation': [ { 'name': 'Critical Care Medicine Cumballa Hill Hospital Mumbai Maharashtra '
'India'}]},
{ 'given': 'Ahsan',
'family': 'Ahmed',
'sequence': 'additional',
'affiliation': [ { 'name': 'Anesthesiology and Critical Care KPC Medical College and '
'Hospital Kolkata West Bengal India'}]},
{ 'given': 'Ajith Kumar',
'family': 'AK',
'sequence': 'additional',
'affiliation': [ { 'name': 'Critical Care Medicine Manipal Hospitals Bengaluru Karnataka '
'India'}]},
{ 'given': 'Kanwalpreet',
'family': 'Sodhi',
'sequence': 'additional',
'affiliation': [{'name': 'Department of Critical CareDeep Hospital Ludhiana Punjab India'}]},
{ 'given': 'Kishore',
'family': 'Mangal',
'sequence': 'additional',
'affiliation': [{'name': 'Critical Care Eternal Hospital Jaipur Rajasthan India'}]},
{ 'given': 'Manoj K.',
'family': 'Singh',
'sequence': 'additional',
'affiliation': [ { 'name': 'Critical Care & Sleep Medicine Apollo Hospital Ahmedabad '
'Gujarat India'}]},
{ 'given': 'Nitesh',
'family': 'Gupta',
'sequence': 'additional',
'affiliation': [ { 'name': 'Department of Pulmonary Critical Care and Sleep Medicine VMMC '
'and Safdarjung Hospital New Delhi India'}]},
{ 'ORCID': 'http://orcid.org/0000-0002-4497-6772',
'authenticated-orcid': False,
'given': 'Prasanna U.',
'family': 'Bidkar',
'sequence': 'additional',
'affiliation': [ { 'name': 'Department of Anaesthesiology and Critical Care Jawaharlal '
'Institute of Postgraduate Medical Education and Research '
'(JIPMER) Puducherry India'}]},
{ 'given': 'Ranvir S.',
'family': 'Tyagi',
'sequence': 'additional',
'affiliation': [ { 'name': 'Department of Anaesthesia and Critical Care Medicine Synergy '
'Plus Hospital Agra Uttar Pradesh India'}]},
{ 'given': 'Reshu G.',
'family': 'Khanikar',
'sequence': 'additional',
'affiliation': [ { 'name': 'Department of Critical Care Medicine Health City Hospital '
'Guwahati Assam India'}]},
{ 'given': 'Swagata',
'family': 'Tripathy',
'sequence': 'additional',
'affiliation': [ { 'name': 'Anesthesia & Intensive Care All India Institute of Medical '
'Sciences Bhubaneswar Odisha India'}]},
{ 'given': 'Swapna',
'family': 'Khanzode',
'sequence': 'additional',
'affiliation': [ { 'name': 'Medicine and Critical Care Wockhardt Multispecialty Hospital '
'Nagpur Maharashtra India'}]},
{ 'given': 'Kesavarapu',
'family': 'Subba Reddy',
'sequence': 'additional',
'affiliation': [ { 'name': 'Department Of Critical Care Medicine Apollo Health City '
'Hyderabad Telangana India'}]},
{ 'given': 'Saurabh',
'family': 'Saigal',
'sequence': 'additional',
'affiliation': [ { 'name': 'Anaesthesia and Intensive Care All India Institute of Medical '
'Sciences Bhopal Madhya Pradesh India'}]},
{ 'given': 'Vijay Anand',
'family': 'Sivakumar',
'sequence': 'additional',
'affiliation': [ { 'name': 'Velammal Medical college and Research Centre Madurai Tamil Nadu '
'India'}]},
{ 'given': 'Yash',
'family': 'Javeri',
'sequence': 'additional',
'affiliation': [ { 'name': 'Critical Care Medicine and Emergency Medicine Regency Super '
'Specialty Hospital Lucknow Uttar Pradesh India'}]},
{ 'given': 'Seema S.',
'family': 'Tekwani',
'sequence': 'additional',
'affiliation': [ { 'name': 'Division of Pulmonary, Allergy, Critical Care and Sleep Medicine '
'Emory University School of Medicine Atlanta GA USA'}]}],
'member': '98',
'published-online': {'date-parts': [[2021, 7, 18]]},
'reference': [ {'key': 'e_1_2_10_2_1', 'doi-asserted-by': 'publisher', 'DOI': '10.1016/j.dsx.2020.05.041'},
{ 'key': 'e_1_2_10_3_1',
'doi-asserted-by': 'publisher',
'DOI': '10.1016/S1473-3099(20)30120-1'},
{ 'key': 'e_1_2_10_4_1',
'first-page': '1775',
'article-title': 'Case‐fatality rate and characteristics of patients dying in relation to '
'COVID‐19 in Italy',
'volume': '323',
'author': 'Onder G',
'year': '2020',
'journal-title': 'JAMA'},
{'key': 'e_1_2_10_5_1', 'doi-asserted-by': 'publisher', 'DOI': '10.1002/jmv.26041'},
{ 'key': 'e_1_2_10_6_1',
'doi-asserted-by': 'publisher',
'DOI': '10.1016/S0140-6736(20)31857-2'},
{'key': 'e_1_2_10_7_1', 'doi-asserted-by': 'publisher', 'DOI': '10.1001/jama.2020.2648'},
{'key': 'e_1_2_10_8_1', 'doi-asserted-by': 'publisher', 'DOI': '10.1056/NEJMcp2009575'},
{'key': 'e_1_2_10_9_1', 'doi-asserted-by': 'publisher', 'DOI': '10.1111/anae.15201'},
{ 'key': 'e_1_2_10_10_1',
'doi-asserted-by': 'publisher',
'DOI': '10.1164/rccm.202006-2405OC'},
{ 'key': 'e_1_2_10_11_1',
'first-page': 'e208193',
'article-title': 'Variation in US hospital mortality rates for patients admitted with '
'COVID‐19 during the first 6 months of the pandemic',
'volume': '22',
'author': 'Asch DA',
'year': '2020',
'journal-title': 'JAMA Intern Med'},
{ 'key': 'e_1_2_10_12_1',
'doi-asserted-by': 'publisher',
'DOI': '10.1001/jamainternmed.2020.3539'},
{ 'key': 'e_1_2_10_13_1',
'unstructured': 'Government of India Ministry of Health and Family Welfare Directorate '
'General of Health Services.Clinical management protocol: '
'COVID‐19.https://www.mohfw.gov.in/pdf/UpdatedClinicalManagementProtocolforCOVID19dated03072020.pdf. '
'Accessed February 12 2021.'},
{'key': 'e_1_2_10_14_1', 'doi-asserted-by': 'publisher', 'DOI': '10.1056/NEJMoa2021436'},
{ 'key': 'e_1_2_10_15_1',
'unstructured': 'World Health Organisation.Clinical management of COVID‐19. Interim '
'guidance;2020.https://www.who.int/publications/i/item/clinical‐management‐of‐covid‐19. '
'Accessed February 11 2021.'},
{ 'key': 'e_1_2_10_16_1',
'doi-asserted-by': 'publisher',
'DOI': '10.1038/s41379-020-00661-1'},
{'key': 'e_1_2_10_17_1', 'doi-asserted-by': 'publisher', 'DOI': '10.1056/NEJMoa2007764'},
{'key': 'e_1_2_10_18_1', 'doi-asserted-by': 'publisher', 'DOI': '10.1056/NEJMoa2023184'},
{ 'key': 'e_1_2_10_19_1',
'unstructured': 'NIH.The COVID‐19 Treatment Guidelines Panel’s Statement on the Use of '
'Ivermectin for the Treatment of '
'COVID‐19.https://www.covid19treatmentguidelines.nih.gov/statement‐on‐ivermectin/. '
'Accessed February 9 2021.'},
{ 'key': 'e_1_2_10_20_1',
'doi-asserted-by': 'publisher',
'DOI': '10.1016/j.ijid.2020.10.069'},
{'key': 'e_1_2_10_21_1', 'doi-asserted-by': 'publisher', 'DOI': '10.1136/bmj.m3939'},
{'key': 'e_1_2_10_22_1', 'doi-asserted-by': 'publisher', 'DOI': '10.1001/jama.2021.2747'},
{'key': 'e_1_2_10_23_1', 'doi-asserted-by': 'publisher', 'DOI': '10.1001/jama.2020.17023'},
{ 'key': 'e_1_2_10_24_1',
'doi-asserted-by': 'publisher',
'DOI': '10.1097/CCM.0000000000004899'},
{ 'key': 'e_1_2_10_25_1',
'doi-asserted-by': 'publisher',
'DOI': '10.1001/jamainternmed.2020.6557'},
{'key': 'e_1_2_10_26_1', 'doi-asserted-by': 'publisher', 'DOI': '10.1136/bmj.n61'},
{ 'key': 'e_1_2_10_27_1',
'unstructured': 'NICE.COVID‐19 rapid evidence summary: Tocilizumab for '
'COVID‐19.https://www.nice.org.uk/advice/es33/chapter/Product‐overview. '
'Accessed February 9 2021.'},
{ 'key': 'e_1_2_10_28_1',
'doi-asserted-by': 'publisher',
'DOI': '10.1007/s12291-020-00918-1'},
{ 'key': 'e_1_2_10_29_1',
'doi-asserted-by': 'publisher',
'DOI': '10.1016/S0140-6736(20)30566-3'},
{'key': 'e_1_2_10_30_1', 'doi-asserted-by': 'publisher', 'DOI': '10.1016/j.cmi.2020.09.041'},
{ 'key': 'e_1_2_10_31_1',
'doi-asserted-by': 'publisher',
'DOI': '10.1016/S0140-6736(21)00149-5'},
{ 'key': 'e_1_2_10_32_1',
'unstructured': 'News.PRINCIPLE trial finds antibiotics azithromycin and doxycycline not '
'generally effective treatments for '
'COVID‐19.https://www.ox.ac.uk/news/2021‐01‐25‐principle‐trial‐finds‐antibiotics‐azithromycin‐and‐doxycycline‐not‐generally. '
'Accessed February 10 2021.'},
{ 'key': 'e_1_2_10_33_1',
'unstructured': 'NIH.COVID‐19 Treatment Guidelines. Vitamin '
'C.https://www.covid19treatmentguidelines.nih.gov/adjunctive‐therapy/vitamin‐c/. '
'Accessed on February 10 2021.'},
{ 'key': 'e_1_2_10_34_1',
'doi-asserted-by': 'publisher',
'DOI': '10.1186/s12948-020-00139-0'},
{ 'key': 'e_1_2_10_35_1',
'doi-asserted-by': 'publisher',
'DOI': '10.1213/ANE.0000000000005292'},
{ 'key': 'e_1_2_10_36_1',
'unstructured': 'NIH.COVID‐19 Treatment Guidelines. Antithrombotic Therapy in Patients '
'with '
'COVID‐19.https://www.covid19treatmentguidelines.NIH.gov/adjunctive‐therapy/antithrombotic‐therapy/. '
'Accessed February 10 2021.'}],
'container-title': 'International Journal of Clinical Practice',
'original-title': [],
'language': 'en',
'link': [ { 'URL': 'https://onlinelibrary.wiley.com/doi/pdf/10.1111/ijcp.14574',
'content-type': 'application/pdf',
'content-version': 'vor',
'intended-application': 'text-mining'},
{ 'URL': 'https://onlinelibrary.wiley.com/doi/full-xml/10.1111/ijcp.14574',
'content-type': 'application/xml',
'content-version': 'vor',
'intended-application': 'text-mining'},
{ 'URL': 'https://onlinelibrary.wiley.com/doi/pdf/10.1111/ijcp.14574',
'content-type': 'unspecified',
'content-version': 'vor',
'intended-application': 'similarity-checking'}],
'deposited': { 'date-parts': [[2022, 1, 28]],
'date-time': '2022-01-28T06:08:39Z',
'timestamp': 1643350119000},
'score': 1,
'resource': {'primary': {'URL': 'https://onlinelibrary.wiley.com/doi/10.1111/ijcp.14574'}},
'subtitle': [],
'short-title': [],
'issued': {'date-parts': [[2021, 7, 18]]},
'references-count': 35,
'journal-issue': {'issue': '10', 'published-print': {'date-parts': [[2021, 10]]}},
'alternative-id': ['10.1111/ijcp.14574'],
'URL': 'http://dx.doi.org/10.1111/ijcp.14574',
'relation': {},
'ISSN': ['1368-5031', '1742-1241'],
'subject': [],
'container-title-short': 'Int J Clin Pract',
'published': {'date-parts': [[2021, 7, 18]]},
'assertion': [ { 'value': '2021-03-01',
'order': 0,
'name': 'received',
'label': 'Received',
'group': {'name': 'publication_history', 'label': 'Publication History'}},
{ 'value': '2021-06-24',
'order': 1,
'name': 'accepted',
'label': 'Accepted',
'group': {'name': 'publication_history', 'label': 'Publication History'}},
{ 'value': '2021-07-18',
'order': 2,
'name': 'published',
'label': 'Published',
'group': {'name': 'publication_history', 'label': 'Publication History'}}]}
